Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Paul J. Midtlyng"'
Autor:
Paul J. Midtlyng
Publikováno v:
Principles of Fish Immunology ISBN: 9783030854195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e6b7462e542db7dc337461563f51745
https://doi.org/10.1007/978-3-030-85420-1_19
https://doi.org/10.1007/978-3-030-85420-1_19
Publikováno v:
Aquaculture. 473:538-544
The bacterium Moritella viscosa causes classical winter-ulcer disease in seawater-farmed salmonids. Despite widespread vaccination with multi-component vaccines containing the M. viscosa -antigen, disease outbreaks continue to be reported in Norway.
Autor:
Marc B.M. Bracke, C. Martins, Paul J. Midtlyng, Ole Folkedal, Tore S. Kristiansen, Lars Helge Stien, Jonatan Nilsson, O. Breck, J.M. Pettersen
Publikováno v:
Animal Welfare 25 (2016) 1
Animal Welfare, 25(1), 135-149
Animal Welfare, 25(1), 135-149
The present study investigated the operational feasibility of the recently developed Salmon Welfare Index Model (SWIM 1.0) designed for Atlantic salmon (Salmo salar L) in production cages. Ten salmon farms containing spring smolts were visited twice,
Autor:
Anne Berit Romstad, Øystein Evensen, Kjersti Gravningen, Liv Jorun Reitan, Vibeke Emilsen, Paul J. Midtlyng
Publikováno v:
Biologicals. 42:86-90
Batch potency testing of salmonid vaccines is mainly performed by in vivo challenge, which requires a lot of animals and causes severe pain. Due to the animal welfare concerns associated with in vivo immunization challenge tests, methods which could
Publikováno v:
Vaccine. 31:791-796
Salmon farming has increased dramatically over last thirty years and a key to the success is the introduction of protective vaccines. In Norway, almost 100% of all Atlantic salmon are vaccinated prior to sea transfer. This extensive use of vaccines d
Autor:
Paul J. Midtlyng
Publikováno v:
Fish Vaccines ISBN: 9783034809788
This chapter summarises the common methods for demonstrating safety, potency and efficacy of fish vaccines, allowing them to be licensed and marketed as veterinary medicinal products. It comprises a brief overview of clinical method development since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a91b93eff5104f557ab51e7de22c5b22
https://doi.org/10.1007/978-3-0348-0980-1_6
https://doi.org/10.1007/978-3-0348-0980-1_6
Autor:
Lucy J. Robertson, Trygve T. Poppe, Kristoffer Relling Tysnes, Anders Jørgensen, Paul J. Midtlyng
Publikováno v:
Acta Parasitologica. 57:1-6
Although Giardia duodenalis is considered a parasite of mammals, different genotypes have been identified as infecting several species of freshwater and marine fish in Australia. Establishment of G. duodenalis infection in common laboratory zebrafish
Publikováno v:
Aquaculture Research. 42:28-34
Since 1987, the use of antibacterial drugs in Norwegian fish farming has been drastically reduced from about 48 tonnes to approximately 1 tonne annually, varying slightly from year to year. The 649 kg active substance prescribed in 2007 corresponds t
Autor:
Arnfinn Aunsmo, Paul Steinar Valle, M. Sandberg, Øystein Evensen, Paul J. Midtlyng, Rolf B. Larssen, Asgeir Østvik, Eystein Skjerve
Publikováno v:
Aquaculture. 284:19-24
A controlled field trial was conducted on a commercial Atlantic salmon farm employing an improved field trial methodology for quantifying the effects of vaccination on harvest weight. Vaccinated and unvaccinated passive integrated transponder (PIT) t
Autor:
Sandra Bravo, Paul J. Midtlyng
Publikováno v:
Aquaculture. 270:36-42
This study summarises the availability of fish vaccines in Chile in the period 1999–2003. Through a questionnaire survey, data on annual sales per product were obtained from seven pharmaceutical companies and data on the corresponding farmed salmon